Healthy SubjectsDreamDeathNCT03107403
Dreams and Bereavement
A study testing web form in people with Healthy Subjects, run by Hospices Civils de Lyon at 1 site in France.
Trial summary
The aim of the study is to investigate a possible role of dreaming in emotion regulation testing whether dreaming of a close relative recently deceased is correlated with a positive evolution of the bereavement process Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Subjects
- What is being tested?
- web form
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 9 Oct 2018to 9 Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age > or = 18 years old
- the death of a close relative in the last 3 months
Who cannot join
- history of psychiatric and neurologic disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigation of the Links Between Waking-life and Dream Content in the Case of the Death of a Close Relative
The aim of the study is to investigate a possible role of dreaming in emotion regulation testing whether dreaming of a close relative recently deceased is correlated with a positive evolution of the bereavement process
- Conditions
- Healthy Subjects
- Being tested
- web form
- Keywords
- dreams bereavement, emotional, regulation, bereavement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
web formBehavioural
The scale assessing the bereavement process is the one reported in Teissier 2010
| Study group | Role | What they receive |
|---|---|---|
| Healthy subjects | Experimental | Not described Receives: Behavioral: web form |
What is being measured
The primary outcome is the main question the study is designed to answer.
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 1
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 90
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 180
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 270
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 360
Secondary outcomes (5)
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 1
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 90
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 180
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 270
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Measured: Day 360
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2017
- Study start9 Oct 2018
- Primary completion9 Apr 2023
- Study completion9 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy SubjectsStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Alain Nicolas, MD, Principal investigator, Hôpital le Vinatier/Inserm
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03107403
- Sponsor's protocol ID
- 69HCL17_0075
- Other IDs
- 2017-A00640-53
- Acronym
- DreamDeath
- Status last verified
- Feb 2024
- First submitted
- 5 Apr 2017
- Last updated
- 28 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Links Between Waking-life and Dream Content in the Case of the Death of a Close Relative
- ClinicalTrials.gov ID
- NCT03107403
- Acronym / sponsor ID
- DreamDeath / 69HCL17_0075
- Conditions
- Healthy Subjects
- Keywords
- dreams bereavement, emotional, regulation, bereavement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 9 Oct 2018 (actual)
- Primary completion
- 9 Apr 2023 (actual)
- Study completion
- 9 Apr 2023 (actual)
- First posted
- 11 Apr 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to investigate a possible role of dreaming in emotion regulation testing whether dreaming of a close relative recently deceased is correlated with a positive evolution of the bereavement process
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy subjects | Experimental | Behavioral: web form |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- age > or = 18 years old
- the death of a close relative in the last 3 months
Key exclusion criteria (1 listed)
- history of psychiatric and neurologic disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| web formThe scale assessing the bereavement process is the one reported in Teissier 2010 | Behavioural | Healthy subjects |
Primary outcome
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 1
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 90
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 180
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 270
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 360
5 secondary outcomes
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 1
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 90
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 180
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 270
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time frame: Day 360
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2024.
- Individual participant dataSharing planned: No
Related trials for Healthy Subjects
Active, not recruitingPhase 1/2
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Healthy Volunteer, Hypersensitivity Reactions
Active, not recruitingPhase 1/2
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
Enrolling by invitationObservational study
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
Primary Immunodeficiency, DOCK8
Not yet recruiting
Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection
Healthy Volunteer, Malaria
RecruitingPhase 1/2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Sickle Cell Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alain Nicolas, MD principal investigator
Hôpital le Vinatier/Inserm
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing web form in people with Healthy Subjects, run by Hospices Civils de Lyon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process (time frame: Day 1). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.